Chemotherapy-Induced Myelosuppression Treatment Market to Register a Stellar Growth Rate of CAGR of 3.2% During 2018-2028 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Chemotherapy-Induced Myelosuppression Treatment Market to Register a Stellar Growth Rate of CAGR of 3.2% During 2018-2028

Description:

Chemotherapy-Induced Myelosuppression Treatment Market: Increasing Prescription of Chemo-Adjuvant Therapy for Cancer Management to Boost Growth: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028 – PowerPoint PPT presentation

Number of Views:5
Date added: 27 February 2020
Slides: 12
Provided by: Umesh213
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Chemotherapy-Induced Myelosuppression Treatment Market to Register a Stellar Growth Rate of CAGR of 3.2% During 2018-2028


1
Chemotherapy-Induced Myelosuppression Treatment
Market
  • January 2019

Report Id REP-GB-1364 Published On
Jan-2019 Category Healthcare, Pharmaceuticals
Medical Devices
2
About Future Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

SOLUTION
  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
4
Chemotherapy-Induced Myelosuppression Treatment
Market Analysis
  • Research delivers insight into the
    Chemotherapy-Induced Myelosuppression Treatment
    Market  poised to expand at 3.2 CAGR by
    2018-2028
  • VALLEY COTTAGE -- A new study by FMI reveals that
    the chemotherapy-induced myelosuppression
    treatment market is expected to grow at a subdued
    3 y-o-y in 2019. Valued at nearly US 7 billion
    in 2018, gains are likely to be driven by a
    combination of multipronged factors, including,
  • Development of natural product interventions for
    chemotherapy-induced side effects
  • Growing implementation of radiation treatment in
    cancer treatment owing to the associated high
    success rate of chemotherapy
  • Growing RD investments in cancer research
  • The FMI study finds that growth factor drugs
    continued to garner highest revenues in
    the chemotherapy-induced myelosuppression
    treatment market. In 2018, over 73 of the
    chemotherapy-induced myelosuppression treatment
    market revenues were consolidated in the growth
    factors. Gains were especially notable for
    granulocyte-colony stimulating factor or G-CSF,
    which accounted for over 60 of the global
    chemotherapy-induced myelosuppression treatment
    market revenues in 2018.

5
Chemotherapy-Induced Myelosuppression Treatment
Market Analysis
  • The FMI study reveals that erythropoietin-stimulat
    ing agents (ESA) also accounted for a significant
    market share, with revenues likely to grow at
    2.8 in 2019. In April 2017, FDA announced the
    removal of risk evaluation and mitigation
    strategy (REMS) requirement for the use of ESA
    drugs in myelosuppression treatment. The ESAs
    used in the treatment of radiation-induced
    myelosuppression treatment are epoetin alfa and
    darbepoetin alfa. This has led healthcare
    professionals to engage in the practice of
    discussing benefits as well as risks of
    treatments that include ESAs before initiating
    the use.
  • Hematopoietic growth factors have transformed the
    practice of cancer treatment by allowing
    stimulation of production of specific cells. With
    this, use of thrombopoietin receptor agonists is
    expected to rise rapidly at the rate of 3.5 in
    2019.
  • Injectable Drugs Present Higher Therapeutic
    Availability over Orals
  • The FMI study finds that injectable drugs
    accounted for over 97 of the chemotherapy-induced
    myelosuppression treatment market revenues in
    2018. The status-quo will continue in the future,
    however, the oral route of administration is
    expected to garner increasing annual revenues and
    expected to grow at 4.8 in 2019 over 2018.
  • Increasing number of research validations related
    to the benefits of the oral route of
    administration can be attributed to the higher
    growth rate of the segment in the future.
    However, revenues from the injectable route of
    the administration continue to grow steadily on
    the back of their higher therapeutic availability
    over orally administered drugs.

6
Chemotherapy-Induced Myelosuppression Treatment
Market Analysis
  • Market Revenues Consolidated in Neutropenia
    Treatment
  • According to the study, chemotherapy-induced
    myelosuppression treatment market revenues
    heavily consolidated in the neutropenia
    treatment. In 2018, neutropenia indication
    accounted for over 62 of market revenues. As
    neutropenia is one of the most common side
    effects of chemotherapy wherein prolongation of
    the same can lead to life-threatening infections.
    Owing to the severity of the implications,
    chemotherapy-induced myelosuppression
    therapeutics are heavily used in the treatment of
    neutropenia.
  • Anemia and thrombocytopenia indications also
    utilize chemotherapy-induced myelosuppression
    treatment therapeutics. The study finds that
    revenues in the thrombocytopenia treatment will
    grow at 3.7 y-o-y in 2019.
  • Retail Pharmacies Most Prominent Sales Channel
  • The study opines that chemotherapy-induced
    myelosuppression treatment therapeutics sales
    remain higher through retail pharmacies.
    Suppliers of these therapeutics have extensive
    distribution network with international retail
    pharmacies. Due to this, retail pharmacies
    accounted for over 48 of the chemotherapy-induced
    myelosuppression treatment market revenues in
    2018.

7
Chemotherapy-Induced Myelosuppression Treatment
Market Analysis
  • Owing to heavy integration of pharmacies in the
    hospitals, distribution of chemotherapy-induced
    myelosuppression treatment therapeutics through
    hospital pharmacies also account for a
    considerable share of the market revenues. The
    study finds that hospital pharmacies can be
    called the second largest distributor of
    chemotherapy-induced myelosuppression treatment
    therapeutics owing to their 45 of the market
    revenues.
  • US The Worlds Largest Chemotherapy-induced
    Myelosupression Treatment Market
  • FMI reveals that North America accounted for over
    82 of the revenues in chemotherapy-induced
    myelosuppression treatment market in 2018.
    Presence of leading cancer therapeutics
    providers, significant RD investments and
    established healthcare sector contribute to the
    bulk of market revenues. The U.S. remains the
    largest consumer of the chemotherapy-induced
    myelosuppression treatment market. 
  • Market revenues in the APEJ region are likely to
    grow at higher rate owing to improving healthcare
    facility and growing penetration of advanced
    cancer care treatments. China, followed by India,
    accounts for the highest market revenues in APEJ
    owing to improving economic scenario and
    developing healthcare infrastructure.

8
Chemotherapy-Induced Myelosuppression Treatment
Market Analysis
  • More from Healthcare, Pharmaceuticals and Medical
    Devices Market
  • Retinal Biologics Market Segmentation by Drug
    Class (VEGF-An antagonist, TNF-a inhibitor) by
    Indication (Macular Degeneration, Diabetic
    Retinopathy, Diabetic Macular Edema, Uveitis,
    Others) by Distributional Channel (Institutional
    Sales, Brain Monitoring System Market Segmentation
    By Product Type (Functional Near-Infrared
    Spectroscopy (fNIRS), Electroencephalography
    (EEG) Systems, Magnetoencephalography (MEG)
    Systems, MRI Systems, Other Brain Monitoring
    Systems) By Modality (Portable/Handheld Systems,
    Standalone Systems) By End User (Hospitals,
    Ambulatory Surgical Centers, Clinics, Pediatric
    Neonatal Intensive care Units .
  • 3D Cell Culture Market Segmentation By Product
    Type (Scaffold-Free 3D Cell Culture,
    Scaffold-Based 3D Cell Culture) By Applications
    (Drug Discovery, Tissue Regeneration
    Regenerative Medicines, Cancer Research, Stem
    Cell Technology, Others) By End User
    (Biotechnology and Pharmaceuticals Industries,
    Hospital Laboratories, Academic Research
    Institutes, Contract Research Organizations.
  • Press-release Source - https//www.globenewswire.c
    om/news-release/2019/02/04/1709903/0/en/Chemothera
    py-Induced-Myelosuppression-Treatment-Market-is-Po
    ised-to-Exhibit-A-Moderate-3-2-CAGR-by-2028-Future
    -Market-Insights.html

9
Chemotherapy-Induced Myelosuppression Treatment
Market Analysis
  • More Related Press-release-
  • https//marketresearchcentre.business.blog/2020/02
    /25/necrotic-enteritis-treatment-market-research-t
    o-witness-a-pronounce-growth-during-2018-2028/
  • https//medium.com/_at_mahi041988/necrotic-enteritis-
    treatment-market-research-will-reflect-significant
    -growth-prospects-during-7f965a44b1d3
  • https//www.agreatertown.com/valley_cottage_ny/nec
    rotic_enteritis_treatment_market_research_to_hold_
    a_high_potential_for_growth_by_2018_2028_000754024
    4
  • About Us
  • Future Market Insights (FMI) is a leading market
    intelligence and consulting firm. We deliver
    syndicated research reports, custom research
    reports and consulting services which are
    personalized in nature. FMI delivers a complete
    packaged solution, which combines current market
    intelligence, statistical anecdotes, technology
    inputs, valuable growth insights and an aerial
    view of the competitive framework and future
    market trends.

10
Chemotherapy-Induced Myelosuppression Treatment
Market Analysis
  • Contact Us Mr. Abhishek Budholiya 616 Corporate
    Way, Suite 2-9018 Valley Cottage, NY 10989 United
    States T 1-347-918-3531 F 1-845-579-5705 T
    (UK) 44(0)20-7692-8790 Sales sales_at_futuremarket
    insights.com

11
To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contact Hari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor, 207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
About PowerShow.com